Navigation Links
BioMS Medical Announces Second Quarter 2008 Results
Date:8/12/2008

nt of SPMS. Enrollment for the randomized, double-blind study was initiated in June, 2007 and on July 31, 2008, BioMS completed full recruitment of approximately 510 patients at 68 sites across the U.S. To date, the DSMB has conducted two reviews of the data from this trial and has recommended it continue.

(x) MINDSET-01: A phase II clinical trial evaluating MBP8298 (dirucotide) for the treatment of relapsing-remitting MS (RRMS). The randomized, double-blind study has completed recruitment with 218 patients enrolled at 24 trial sites in six countries across Europe. The DSMB has completed five safety reviews to date and recommended that the trial continue as per the protocol. Completion of the trial is expected at the end of 2008 with results anticipated in the first half of 2009.

Licensing and Development Agreement

On December 17, 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to MBP8298 (dirucotide). Under the terms of the agreement, Lilly and BioMS will collaborate on the development of MBP8298 (dirucotide) and will also share in certain development costs with Lilly being responsible for future research and development, manufacturing and marketing activities. The transaction closed on January 25, 2008 with the receipt of an upfront payment of US$87 million. BioMS has the potential to receive additional development and sales milestones of up to US $410 million and escalating royalties on sales commensurate with the current stage of development of the product if MBP8298 (dirucotide) is commercialized.

Financial Results

The consolidated net loss for the three months ended June 30, 2008 was $0.4 million or ($0.00) per share compared to a consolidated net loss of $11.8 million or ($0.14) per share for the three months ended June 30, 2007. The consolidated net loss for the six months ended June 30, 2008 was $7.1 million or ($0.08) per share compared to a consolid
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... Managing the transition from perimenopause to po...ewswire/ -- The increasing frequency and intensity...periencing menopause. OBG Management and The Jo...a supplement titled Vasomotor symptoms: Managing ... . In this supplement, James McGregor, MD, CM and ...
(Date:12/2/2008)... PHILADELPHIA, Dec. 2 e..., a leading provider of centralized ECG and eClini...armaceutical, biotechnology,medical device and r...l J.,McKelvey, the Company,s President and Chief ...,s Chief Financial Officer, are scheduled to prese...
(Date:12/2/2008)... TAMPA, Fla., Dec. 2 Associated C...ology group practice that operates seven locations...has selected Sage Intergy EHR,electronic health r...on. The,Cherry Hill, N.J.-based practice, which c... deploy the single-database, integrated solution t...
(Date:12/2/2008)... CHENGDU, China, Dec. 2 /PRNewswire-Asia-FirstCal...roNext: TPI), a manufacturer and supplier,of mode...in Chengdu, China,today announced the implementa...egorize both distributors and hospital clients int...and marketing structure. , The new strategy...
Breaking Biology Technology:eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 4Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3
...Roche Discovery Welwyn, 40 Broadwater Road, Welwyn...nt Address: Analytical Sciences, , Syngen...racknell, Berkshire, , RG42 6EY, UK, ...e use of the Bio-Rad PROTEAN Plus Dodeca cell (Fig...ls with preparative protein loads. The Dodeca , ...
... and Carolyn Seggerson 2 , 1 Tech/Aid, , ... 2 Bio-Rad Laboratories, , Inc., 2000 Alf... , Introduction , Running PCR...uming procedure. , It is common to hand c..., A gel of such large size is difficult to...
, , , , back to top
...ction , Amplification of DNA through the...ighly sensitive method capable of copying millions...lecule. 1 Because of the extreme sensitivity of t... previous reactions can result in false positives ...n can be avoided by using positive , disp...
Other Biology Technology:Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 2Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 3Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 4Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 5Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 2Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 3Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 4Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 2Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 3
(Date:12/2/2008)...views of nutrition related topics raises unique ch...icine. In a new article, a team of researchers use...s, and limitations of systematic reviews relevant ...he results. , Systematic reviews, also referred...ssessments with pre-specified questions that can b...
(Date:12/1/2008)...- The International Atomic Energy Agency (IAEA) to...eding technique that could bolster efforts aimed a...p. , IAEA scientists use radiation to produce im...imate conditions such as drought or flood, or that...s. Called mutation induction, the technique is saf...
(Date:12/1/2008)...sts around the world may benefit from a powerful n...help them to home in on the parts of proteins most...D, associate professor of pathology and of genetic...ecently launched the novel bioinformatics tool, wh...the role different proteins play in a wide array o...
(Date:12/1/2008)...niversity of Florida, keeper of the world,s shark ...records collection for another toothy marine preda...rum or "saw" that makes it a popular curio item an...orical and cultural icon that is rapidly disappear...urator of both the International Shark Attack File...
Breaking Biology News(10 mins):Experts discuss applying systematic review to the field of nutrition 2Nuclear science for food security 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Endangered sawfish focus of national collection and recovery efforts 2AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 1AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 2AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 3AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 4Springer launches new journal in musculoskeletal medicine 7194 1Springer launches new journal in musculoskeletal medicine 7194 2FDA Mulls Cutting Salt in Processed Foods 7192 1FDA Mulls Cutting Salt in Processed Foods 7192 2FDA Mulls Cutting Salt in Processed Foods 7192 3FDA Mulls Cutting Salt in Processed Foods 7192 4Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 1Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 2Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 3Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 4
...sity after the end-Cretaceous mass extinction was ...ng to paleontologists. New fossil evidence shows t...diversity were severely out of balance, not linked... million years ago. Labeled the K-T extinction, it...aleocene Epoch. , "The K-T caused major extinctio...
...volving five major food crops grown under carbon-d...ing dramatically less bounty than those raised in ...ons ?and scientists warn that global food supplies...rategies. , The new findings are based on on-going...t Urbana-Champaign and results gleaned from five o...
...archers have developed a way to synthesize a cance...ity to learn how it works. , Derived from a fungus... cave, the chemical tricks certain cancer cells in..., "In 2000, scientists in Japan discovered that t...as a prototype anticancer agent, but no one has be...
...delivered by a robotic arm eradicated lung tumors ...ment, medical physicist Cihat Ozhasoglu, Ph.D. of ...eport in early August at the 48th Annual Meeting o...ne in Orlando. Although it is too early to determ...oglu and his colleagues find promise in this new a...
Other Biology News:Insect predation sheds light on food web recovery after the dinosaur extinction 2Insect predation sheds light on food web recovery after the dinosaur extinction 3Insect predation sheds light on food web recovery after the dinosaur extinction 4Food-crop yields in future greenhouse-gas conditions lower than expected 2New lab technique churns out fungus' potential cancer fighter 2Radiation-armed robot rapidly destroys human lung tumors 2
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody
...hthoyl-VF-CHO White lyophilized solid. PROTECT F...ble, reversible inhibitor of γ-secretase. Eq...ED 50 = 2.6 μM) and Aβ x-42 (ED 50 = 2....he Amyloid Precursor Protein Swedish mutants. Pur...
Mlu I from New England Biolabs
Corticoliberin
Biology Products: